Perceptive Advisors’s VASCULAR BIOGENICS LTD ORD SHS (ISR) VBLX Stock Holding History

Perceptive Advisors’s Portfolio VBLX Stock Details VBLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-500,000	Closed	-$2.96M	–	200
2014 Q4	$2.96M	Buy	+500,000	New	+$2.96M	0.25%	72

Perceptive Advisors's VBLX Position: Q1 2015 in Review

Perceptive Advisors sold out of VASCULAR BIOGENICS LTD ORD SHS (ISR) (VBLX) in Q1 2015, closing a stake of 500,000 shares — an estimated $2.96M sold.

Perceptive Advisors first reported a position in VBLX in Q4 2014 and held it in 1 quarter. The position peaked at $2.96M in Q4 2014. 0 funds tracked by Wall St. Rank hold VBLX as of Q1 2015.

Perceptive Advisors reported no remaining VASCULAR BIOGENICS LTD ORD SHS (ISR) position as of Q1 2015 after selling out during the quarter.
Perceptive Advisors sold 500,000 VASCULAR BIOGENICS LTD ORD SHS (ISR) shares in Q1 2015, an estimated $2.96M.
Perceptive Advisors first reported a position in VASCULAR BIOGENICS LTD ORD SHS (ISR) in Q4 2014 and held it in 1 quarter.
Perceptive Advisors's VASCULAR BIOGENICS LTD ORD SHS (ISR) position peaked at $2.96M in Q4 2014.
0 funds tracked by Wall St. Rank held VASCULAR BIOGENICS LTD ORD SHS (ISR) as of Q1 2015.

Based on Perceptive Advisors's 13F filing for Q1 2015, filed 15 May 2015.